StockData

Vanda Pharmaceuticals Inc. (VNDA) stock

VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.81+0.00 (0.00%)

Close on Nov 17, 2026Market cap $230.39MP/E –Yield –

Vanda Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Vanda Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2026 was -77.6%. For fiscal 2025 it was -70.0%, against -20.5% the year before. The highest annual figure on record is 40.0% in fiscal 2014.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-70.0%−49.5
FY2024Dec 31, 2024-20.5%−13.2
FY2023Dec 31, 2023-7.2%−9.7
FY2022Dec 31, 20222.5%−13.2
FY2021Dec 31, 202115.7%+4.7
FY2020Dec 31, 202011.0%+0.9
FY2019Dec 31, 201910.0%−1.2
FY2018Dec 31, 201811.3%+21.5
FY2017Dec 31, 2017-10.2%+2.5
FY2016Dec 31, 2016-12.7%+23.8
FY2015Dec 31, 2015-36.6%−76.6
FY2014Dec 31, 201440.0%+102.6
FY2013Dec 31, 2013-62.6%+26.6
FY2012Dec 31, 2012-89.2%−54.9
FY2011Dec 31, 2011-34.2%−59.0
FY2010Dec 31, 201024.8%+815.2
FY2009Dec 31, 2009-790.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-33.7%+21.9
Q2 FY2026Jun 30, 2026-126.3%−53.1
Q1 FY2026Mar 31, 2026-97.1%−15.1
Q4 FY2025Dec 31, 2025-70.5%−51.2
Q3 FY2025Sep 30, 2025-55.6%−32.5
Q2 FY2025Jun 30, 2025-73.2%−53.1
Q1 FY2025Mar 31, 2025-82.0%−62.5
Q4 FY2024Dec 31, 2024-19.3%−3.7
Q3 FY2024Sep 30, 2024-23.1%−7.6
Q2 FY2024Jun 30, 2024-20.1%−13.9
Q1 FY2024Mar 31, 2024-19.5%−22.7
Q4 FY2023Dec 31, 2023-15.7%−26.0
Q3 FY2023Sep 30, 2023-15.4%−21.4
Q2 FY2023Jun 30, 2023-6.2%−11.6
Q1 FY2023Mar 31, 20233.2%+15.9
Q4 FY2022Dec 31, 202210.3%−2.4
Q3 FY2022Sep 30, 20226.0%−9.5
Q2 FY2022Jun 30, 20225.4%−12.8
Q1 FY2022Mar 31, 2022-12.7%−29.2
Q4 FY2021Dec 31, 202112.7%−2.8
Q3 FY2021Sep 30, 202115.4%+2.6
Q2 FY2021Jun 30, 202118.2%+3.5
Q1 FY2021Mar 31, 202116.5%+16.7
Q4 FY2020Dec 31, 202015.4%+8.5
Q3 FY2020Sep 30, 202012.8%−5.2
Q2 FY2020Jun 30, 202014.7%−2.0
Q1 FY2020Mar 31, 2020-0.2%+4.2
Q4 FY2019Dec 31, 20197.0%−10.3
Q3 FY2019Sep 30, 201918.1%+5.4
Q2 FY2019Jun 30, 201916.8%+8.5
Q1 FY2019Mar 31, 2019-4.4%−10.0
Q4 FY2018Dec 31, 201817.3%+22.1
Q3 FY2018Sep 30, 201812.7%+24.6
Q2 FY2018Jun 30, 20188.3%+12.8
Q1 FY2018Mar 31, 20185.6%+26.7
Q4 FY2017Dec 31, 2017-4.9%−3.1
Q3 FY2017Sep 30, 2017-11.9%–
Q2 FY2017Jun 30, 2017-4.6%–
Q1 FY2017Mar 31, 2017-21.1%–
Q4 FY2016Dec 31, 2016-1.7%–

More Vanda Pharmaceuticals figures

See a number that looks wrong?